Internal Medicine, Gastroenterology · Salem, OR
NPI
1063576437
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
875 Oak St SE, Suite 3010
Salem, OR, 97301
Phone (503) 399-7520
Medicare paid, 2024
$73K
954 services
Medicare patients, 2024
305
Average age 71
Drug cost, 2024
$248K
1,210 prescriptions
Company payments, 2024
$17.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia C Kao was code 88305 (surgical pathology examination), 361 times for 144 patients. In total Patricia C Kao billed 954 services in 39 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 361 | 144 | $25.60 | $9,242 |
| 45385 Colonoscopy - Lesion Removal | Facility | 131 | 130 | $197.18 | $26K |
| 88313 Surgical Pathology Examination | Office | 118 | 51 | $53.17 | $6,274 |
| 43239 Upper GI Endoscopy | Facility | 74 | 73 | $66.69 | $4,935 |
| 88312 Surgical Pathology Examination | Office | 49 | 44 | $65.70 | $3,219 |
| 91010 Test - Miscellaneous | Facility | 36 | 36 | $47.20 | $1,699 |
| 99222 Hospital E&M - Initial | Facility | 27 | 27 | $95.67 | $2,583 |
| 45380 Lower GI Endoscopy - Other | Facility | 26 | 26 | $75.28 | $1,957 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 13 | $56.65 | $963 |
| 43235 Upper GI Endoscopy | Facility | 15 | 15 | $80.49 | $1,207 |
| 43249 Upper GI Endoscopy | Facility | 15 | 15 | $93.49 | $1,402 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 11 | 11 | $158.56 | $1,744 |
By year: 2022 $62K for 659 services; 2023 $73K for 830 services; 2024 $73K for 954 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 361 | 144 | $25.60 | $9,242 |
| 88313 Surgical Pathology Examination | 118 | 51 | $53.17 | $6,274 |
| 88312 Surgical Pathology Examination | 49 | 44 | $65.70 | $3,219 |
Medicare prescription drug claims, 2024
In 2024, the drug Patricia C Kao prescribed most often to Medicare patients was Omeprazole, with 163 prescriptions and refills. In total Patricia C Kao wrote 1,210 Medicare prescriptions that cost $248K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 163 | 359 | 64 | $4,003 |
| Famotidine Generic | 153 | 412 | 68 | $3,223 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 142 | 142 | 141 | $9,247 |
| Pantoprazole Sodium Generic | 93 | 206 | 39 | $1,835 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 57 | 57 | 56 | $1,028 |
| Promethazine Hcl Generic | 53 | 55 | Under 11 | $1,384 |
| Prochlorperazine Edisylate Generic | 46 | 46 | Under 11 | $4,756 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 45 | 45 | Under 11 | $372 |
| Metoclopramide Hcl Generic | 40 | 40 | Under 11 | $502 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 28 | 28 | 28 | $456 |
| Azathioprine Generic | 28 | 60 | Under 11 | $645 |
| Ursodiol Generic | 28 | 65 | Under 11 | $5,542 |
| Lactulose Generic | 23 | 23 | Under 11 | $684 |
| Sucralfate Generic | 22 | 44 | 16 | $4,635 |
| Eliquis Apixaban | 21 | 29 | Under 11 | $17K |
Brand drugs: 187 claims; generic drugs: 1,023 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Patricia C Kao $17.36 ($17.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Celgene Corporation with $17.36.
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation BMY | 1 | $17.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.